1. Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study. Issue 6 (1st April 2019) Authors: Pegourie, Brigitte; Karlin, Lionel; Benboubker, Lotfi; Orsini‐Piocelle, Frédérique; Tiab, Mourad; Auger‐Quittet, Sophie; Rodon, Philippe; Royer, Bruno; Leleu, Xavier; Bareau, Benoit; Cliquennois, Manuel; Fuzibet, Jean‐Gabriel; Voog, Eric; Belhadj‐Merzoug, Karim; Decaux, Olivier; Rey, Philippe; Sl... Journal: American journal of hematology Issue: Volume 94:Issue 6(2019:Jun.) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study. Issue 2 (1st January 2023) Authors: Dumontet, Charles; Demangel, Delphine; Galia, Perrine; Karlin, Lionel; Roche, Laurent; Fauvernier, Mathieu; Golfier, Camille; Laude, Marie‐Charlotte; Leleu, Xavier; Rodon, Philippe; Roussel, Murielle; Azaïs, Isabelle; Doyen, Chantal; Slama, Borhane; Manier, Salomon; Decaux, Olivier; Pertesi, Maro... Journal: American journal of hematology Issue: Volume 98:Issue 2(2023) Page Start: 264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study. Issue 2 (February 2018) Authors: Dartigeas, Caroline; Van Den Neste, Eric; Léger, Julie; Maisonneuve, Hervé; Berthou, Christian; Dilhuydy, Marie-Sarah; De Guibert, Sophie; Leprêtre, Stéphane; Béné, Marie C; Nguyen-Khac, Florence; Letestu, Rémi; Cymbalista, Florence; Rodon, Philippe; Aurran-Schleinitz, Thérèse; Vilque, Jean-Pierr... Journal: Lancet Issue: Volume 5:Issue 2(2018) Page Start: e82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗